In Vitro Activity of S-3578, a New Broad-Spectrum Cephalosporin Active against Methicillin-Resistant Staphylococci
| Autor: | Takaji Fujimura, Isamu Yoshida, Shogo Kuwahara, Yoshinori Yamano, Jingoro Shimada |
|---|---|
| Rok vydání: | 2003 |
| Předmět: |
Imipenem
Time Factors medicine.drug_class Staphylococcus Cefepime Cephalosporin Population Microbial Sensitivity Tests Muramoylpentapeptide Carboxypeptidase medicine.disease_cause Staphylococcal infections beta-Lactamases Microbiology Bacterial Proteins Staphylococcus epidermidis medicine Humans Penicillin-Binding Proteins Pharmacology (medical) education Pharmacology education.field_of_study biology biochemical phenomena metabolism and nutrition Staphylococcal Infections bacterial infections and mycoses biology.organism_classification medicine.disease Cephalosporins Kinetics Infectious Diseases Hexosyltransferases Susceptibility Staphylococcus aureus Peptidyl Transferases Vancomycin Methicillin Resistance Carrier Proteins Protein Binding medicine.drug |
| Zdroj: | Antimicrobial Agents and Chemotherapy. 47:923-931 |
| ISSN: | 1098-6596 0066-4804 |
| DOI: | 10.1128/aac.47.3.923-931.2003 |
| Popis: | The in vitro antibacterial activity of S-3578, a new parenteral cephalosporin, against clinical isolates was evaluated. The MICs of the drug at which 90% of the isolates were inhibited were 4 μg/ml for methicillin-resistant Staphylococcus aureus (MRSA) and 2 μg/ml for methicillin-resistant Staphylococcus epidermidis , which were fourfold higher than and equal to those of vancomycin, respectively. The anti-MRSA activity of S-3578 was considered to be due to its high affinity for penicillin-binding protein 2a (50% inhibitory concentration, 4.5 μg/ml). In time-kill studies with 10 strains each of MRSA and methicillin-susceptible S. aureus , S-3578 caused more than a 4-log 10 decrease of viable cells on the average at twice the MIC after 24 h of exposure, indicating that it had potent bactericidal activity. Furthermore, in population analysis of MRSA strains with heterogeneous or homogeneous resistance to imipenem, no colonies emerged from about 10 9 cells on agar plates containing twice the MIC of S-3578, suggesting the low frequency of emergence of S-3578-resistant strains from MRSA. S-3578 was also highly active against penicillin-resistant Streptococcus pneumoniae (PRSP), with a MIC 90 of 1 μg/ml, which was comparable to that of ceftriaxone. S-3578 also had antibacterial activity against a variety of gram-negative bacteria including Pseudomonas aeruginosa , though its activity was not superior to that of cefepime. In conclusion, S-3578 exhibited a broad antibacterial spectrum and, particularly, had excellent activity against gram-positive bacteria including methicillin-resistant staphylococci and PRSP. Thus, S-3578 was considered to be worthy of further evaluation. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|